BioPharmaTrend
News
All Topics
  • AI in Bio
  • Tech Giants
  • Next-Gen Tools
  • Biotech Ventures
  • Industry Movers
  • NeuroTech
  • Interviews
  • Business Intelligence
  • Case Studies
Intelligence
  • Business Intelligence
  • Case Studies
  • Lab
  • Membership
About
  • At a Glance
  • Our Team
  • Advisory Board
  • Citations and Press Coverage
  • Partner Events Calendar
  • Advertise with Us
  • Write for Us
Newsletter
Login/Join
  • AI in Bio
  • Tech Giants
  • Next-Gen Tools
  • Biotech Ventures
  • Industry Movers
  • NeuroTech
This company is included in Intelligence Lab

Degron Therapeutics

Degron Therapeutics logo

Website
http://www.degrontx.com/en/index.php
Founded
2021

Shanghai-headquartered Degron Therapeutics was founded relatively recently, in April 2021, aiming to discover novel molecular glue degraders for cancer treatment and other therapeutic areas. The company spun out of the lab of cofounder Yong Cang, a professor at ShanghaiTech University, and is based at JLabs, an incubator of Johnson & Johnson. In June 2022, Degron raised $22 million in series A financing, which will be used to advance the company's GlueXplorer platform. GlueXplorer is a molecular glue-based targeted protein degradation platform aiming to accelerate the development of novel drugs for previously undruggable targets in oncology, inflammation, metabolic disease, rare diseases, and other therapeutic areas. Degron's platform uses a combination of phenotypic screening, proteomic screening, and AI to predict novel targets and accelerate compound discovery.


Articles Mentioning This Company

11 AI-powered Drug Discovery Startups Founded in 2021

Nov. 14, 2022     Articles
The community of AI-driven biotech companies is continuously expanding, adding new players to the drug discovery race. In 2021 several dozen companies with AI-fueled platforms were founded, and they successfully continued raising funding and establishing strategic collaborations to expand their pipelines and improve computational capabilities.  In this report, we summarize …

BiopharmaTrend.com

Where Tech Meets Bio
mail  Newsletter
in  LinkedIn
x  X
rss  RSS Feed

About


  • What we do
  • Citations and Press Coverage
  • Terms of Use
  • Privacy Policy
  • Disclaimer

We Offer


  • Newsletter
  • Business Intelligence
  • Interviews
  • Partner Events
  • Case Studies

Opportunities


  • Advertise
  • Lab Access
  • Lab Membership
  • Write for Us
  • Contact Us

© BPT Analytics LTD 2025
We use cookies to personalise content and to analyse our traffic. You consent to our cookies if you continue to use our website. Read more details in our cookies policy.